ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-29J17753
Home | Market Reports | Health| Nursing
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
BUY CHAPTERS

Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024

Code: QYRE-Auto-29J17753
Report
August 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELiT
Nordion
Polatom

Radiopharmaceutical for Nuclear Medicine Market

The global Radiopharmaceutical for Nuclear Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Radiopharmaceutical for Nuclear Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radiopharmaceutical for Nuclear Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Radiopharmaceutical for Nuclear Medicine in Nuclear Medicine Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Radiopharmaceutical for Nuclear Medicine include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical for Nuclear Medicine.
The Radiopharmaceutical for Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radiopharmaceutical for Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical for Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Radiopharmaceutical for Nuclear Medicine Market Report

Report Metric Details
Report Name Radiopharmaceutical for Nuclear Medicine Market
Segment by Type
  • Carbon-14
  • Technetium-99m
  • Iodine-131
  • Iodine-125
  • Others
Segment by Application
  • Nuclear Medicine Diagnosis
  • Nuclear Medicine Treatment
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Radiopharmaceutical for Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radiopharmaceutical for Nuclear Medicine Market report?

Ans: The main players in the Radiopharmaceutical for Nuclear Medicine Market are NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom

What are the Application segmentation covered in the Radiopharmaceutical for Nuclear Medicine Market report?

Ans: The Applications covered in the Radiopharmaceutical for Nuclear Medicine Market report are Nuclear Medicine Diagnosis, Nuclear Medicine Treatment, Others

What are the Type segmentation covered in the Radiopharmaceutical for Nuclear Medicine Market report?

Ans: The Types covered in the Radiopharmaceutical for Nuclear Medicine Market report are Carbon-14, Technetium-99m, Iodine-131, Iodine-125, Others

Recommended Reports

Radiopharmaceuticals Markets

Nuclear Therapy Devices

Imaging & Equipment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Carbon-14
1.2.3 Technetium-99m
1.2.4 Iodine-131
1.2.5 Iodine-125
1.2.6 Others
1.3 Market by Application
1.3.1 Global Radiopharmaceutical for Nuclear Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Nuclear Medicine Diagnosis
1.3.3 Nuclear Medicine Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical for Nuclear Medicine Market Perspective (2019-2030)
2.2 Global Radiopharmaceutical for Nuclear Medicine Growth Trends by Region
2.2.1 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Radiopharmaceutical for Nuclear Medicine Historic Market Size by Region (2019-2024)
2.2.3 Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Region (2025-2030)
2.3 Radiopharmaceutical for Nuclear Medicine Market Dynamics
2.3.1 Radiopharmaceutical for Nuclear Medicine Industry Trends
2.3.2 Radiopharmaceutical for Nuclear Medicine Market Drivers
2.3.3 Radiopharmaceutical for Nuclear Medicine Market Challenges
2.3.4 Radiopharmaceutical for Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical for Nuclear Medicine Players by Revenue
3.1.1 Global Top Radiopharmaceutical for Nuclear Medicine Players by Revenue (2019-2024)
3.1.2 Global Radiopharmaceutical for Nuclear Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Radiopharmaceutical for Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Radiopharmaceutical for Nuclear Medicine Revenue
3.4 Global Radiopharmaceutical for Nuclear Medicine Market Concentration Ratio
3.4.1 Global Radiopharmaceutical for Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical for Nuclear Medicine Revenue in 2023
3.5 Global Key Players of Radiopharmaceutical for Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Radiopharmaceutical for Nuclear Medicine, Product and Application
3.7 Global Key Players of Radiopharmaceutical for Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical for Nuclear Medicine Breakdown Data by Type
4.1 Global Radiopharmaceutical for Nuclear Medicine Historic Market Size by Type (2019-2024)
4.2 Global Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Type (2025-2030)
5 Radiopharmaceutical for Nuclear Medicine Breakdown Data by Application
5.1 Global Radiopharmaceutical for Nuclear Medicine Historic Market Size by Application (2019-2024)
5.2 Global Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Radiopharmaceutical for Nuclear Medicine Market Size (2019-2030)
6.2 North America Radiopharmaceutical for Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024)
6.4 North America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical for Nuclear Medicine Market Size (2019-2030)
7.2 Europe Radiopharmaceutical for Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024)
7.4 Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size (2019-2030)
8.2 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical for Nuclear Medicine Market Size (2019-2030)
9.2 Latin America Radiopharmaceutical for Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024)
9.4 Latin America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size (2019-2030)
10.2 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Details
11.1.2 NRG Business Overview
11.1.3 NRG Radiopharmaceutical for Nuclear Medicine Introduction
11.1.4 NRG Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.1.5 NRG Recent Development
11.2 NTP Radioisotopes
11.2.1 NTP Radioisotopes Company Details
11.2.2 NTP Radioisotopes Business Overview
11.2.3 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Introduction
11.2.4 NTP Radioisotopes Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.2.5 NTP Radioisotopes Recent Development
11.3 JSC Isotope
11.3.1 JSC Isotope Company Details
11.3.2 JSC Isotope Business Overview
11.3.3 JSC Isotope Radiopharmaceutical for Nuclear Medicine Introduction
11.3.4 JSC Isotope Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.3.5 JSC Isotope Recent Development
11.4 ANSTO
11.4.1 ANSTO Company Details
11.4.2 ANSTO Business Overview
11.4.3 ANSTO Radiopharmaceutical for Nuclear Medicine Introduction
11.4.4 ANSTO Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.4.5 ANSTO Recent Development
11.5 China National Nuclear Corporation (CNNC)
11.5.1 China National Nuclear Corporation (CNNC) Company Details
11.5.2 China National Nuclear Corporation (CNNC) Business Overview
11.5.3 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Introduction
11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.5.5 China National Nuclear Corporation (CNNC) Recent Development
11.6 IRE ELIT
11.6.1 IRE ELIT Company Details
11.6.2 IRE ELIT Business Overview
11.6.3 IRE ELIT Radiopharmaceutical for Nuclear Medicine Introduction
11.6.4 IRE ELIT Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.6.5 IRE ELIT Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Radiopharmaceutical for Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.7.5 Nordion Recent Development
11.8 Polatom
11.8.1 Polatom Company Details
11.8.2 Polatom Business Overview
11.8.3 Polatom Radiopharmaceutical for Nuclear Medicine Introduction
11.8.4 Polatom Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
11.8.5 Polatom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELiT
Nordion
Polatom
List of Tables
 Table 1. Global Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Carbon-14
 Table 3. Key Players of Technetium-99m
 Table 4. Key Players of Iodine-131
 Table 5. Key Players of Iodine-125
 Table 6. Key Players of Others
 Table 7. Global Radiopharmaceutical for Nuclear Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Radiopharmaceutical for Nuclear Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Radiopharmaceutical for Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
 Table 10. Global Radiopharmaceutical for Nuclear Medicine Market Share by Region (2019-2024)
 Table 11. Global Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 12. Global Radiopharmaceutical for Nuclear Medicine Market Share by Region (2025-2030)
 Table 13. Radiopharmaceutical for Nuclear Medicine Market Trends
 Table 14. Radiopharmaceutical for Nuclear Medicine Market Drivers
 Table 15. Radiopharmaceutical for Nuclear Medicine Market Challenges
 Table 16. Radiopharmaceutical for Nuclear Medicine Market Restraints
 Table 17. Global Radiopharmaceutical for Nuclear Medicine Revenue by Players (2019-2024) & (US$ Million)
 Table 18. Global Radiopharmaceutical for Nuclear Medicine Market Share by Players (2019-2024)
 Table 19. Global Top Radiopharmaceutical for Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical for Nuclear Medicine as of 2023)
 Table 20. Ranking of Global Top Radiopharmaceutical for Nuclear Medicine Companies by Revenue (US$ Million) in 2023
 Table 21. Global 5 Largest Players Market Share by Radiopharmaceutical for Nuclear Medicine Revenue (CR5 and HHI) & (2019-2024)
 Table 22. Global Key Players of Radiopharmaceutical for Nuclear Medicine, Headquarters and Area Served
 Table 23. Global Key Players of Radiopharmaceutical for Nuclear Medicine, Product and Application
 Table 24. Global Key Players of Radiopharmaceutical for Nuclear Medicine, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Radiopharmaceutical for Nuclear Medicine Market Size by Type (2019-2024) & (US$ Million)
 Table 27. Global Radiopharmaceutical for Nuclear Medicine Revenue Market Share by Type (2019-2024)
 Table 28. Global Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 29. Global Radiopharmaceutical for Nuclear Medicine Revenue Market Share by Type (2025-2030)
 Table 30. Global Radiopharmaceutical for Nuclear Medicine Market Size by Application (2019-2024) & (US$ Million)
 Table 31. Global Radiopharmaceutical for Nuclear Medicine Revenue Market Share by Application (2019-2024)
 Table 32. Global Radiopharmaceutical for Nuclear Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 33. Global Radiopharmaceutical for Nuclear Medicine Revenue Market Share by Application (2025-2030)
 Table 34. North America Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. North America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
 Table 36. North America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Europe Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
 Table 39. Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
 Table 40. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
 Table 42. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region (2025-2030) & (US$ Million)
 Table 43. Latin America Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Latin America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Latin America Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 47. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
 Table 48. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country (2025-2030) & (US$ Million)
 Table 49. NRG Company Details
 Table 50. NRG Business Overview
 Table 51. NRG Radiopharmaceutical for Nuclear Medicine Product
 Table 52. NRG Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 53. NRG Recent Development
 Table 54. NTP Radioisotopes Company Details
 Table 55. NTP Radioisotopes Business Overview
 Table 56. NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product
 Table 57. NTP Radioisotopes Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 58. NTP Radioisotopes Recent Development
 Table 59. JSC Isotope Company Details
 Table 60. JSC Isotope Business Overview
 Table 61. JSC Isotope Radiopharmaceutical for Nuclear Medicine Product
 Table 62. JSC Isotope Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 63. JSC Isotope Recent Development
 Table 64. ANSTO Company Details
 Table 65. ANSTO Business Overview
 Table 66. ANSTO Radiopharmaceutical for Nuclear Medicine Product
 Table 67. ANSTO Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 68. ANSTO Recent Development
 Table 69. China National Nuclear Corporation (CNNC) Company Details
 Table 70. China National Nuclear Corporation (CNNC) Business Overview
 Table 71. China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product
 Table 72. China National Nuclear Corporation (CNNC) Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 73. China National Nuclear Corporation (CNNC) Recent Development
 Table 74. IRE ELIT Company Details
 Table 75. IRE ELIT Business Overview
 Table 76. IRE ELIT Radiopharmaceutical for Nuclear Medicine Product
 Table 77. IRE ELIT Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 78. IRE ELIT Recent Development
 Table 79. Nordion Company Details
 Table 80. Nordion Business Overview
 Table 81. Nordion Radiopharmaceutical for Nuclear Medicine Product
 Table 82. Nordion Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 83. Nordion Recent Development
 Table 84. Polatom Company Details
 Table 85. Polatom Business Overview
 Table 86. Polatom Radiopharmaceutical for Nuclear Medicine Product
 Table 87. Polatom Revenue in Radiopharmaceutical for Nuclear Medicine Business (2019-2024) & (US$ Million)
 Table 88. Polatom Recent Development
 Table 89. Research Programs/Design for This Report
 Table 90. Key Data Information from Secondary Sources
 Table 91. Key Data Information from Primary Sources
 Table 92. Authors List of This Report


List of Figures
 Figure 1. Radiopharmaceutical for Nuclear Medicine Picture
 Figure 2. Global Radiopharmaceutical for Nuclear Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Radiopharmaceutical for Nuclear Medicine Market Share by Type: 2023 VS 2030
 Figure 4. Carbon-14 Features
 Figure 5. Technetium-99m Features
 Figure 6. Iodine-131 Features
 Figure 7. Iodine-125 Features
 Figure 8. Others Features
 Figure 9. Global Radiopharmaceutical for Nuclear Medicine Market Size by Application (2024-2030) & (US$ Million)
 Figure 10. Global Radiopharmaceutical for Nuclear Medicine Market Share by Application: 2023 VS 2030
 Figure 11. Nuclear Medicine Diagnosis Case Studies
 Figure 12. Nuclear Medicine Treatment Case Studies
 Figure 13. Others Case Studies
 Figure 14. Radiopharmaceutical for Nuclear Medicine Report Years Considered
 Figure 15. Global Radiopharmaceutical for Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global Radiopharmaceutical for Nuclear Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Radiopharmaceutical for Nuclear Medicine Market Share by Region: 2023 VS 2030
 Figure 18. Global Radiopharmaceutical for Nuclear Medicine Market Share by Players in 2023
 Figure 19. Global Top Radiopharmaceutical for Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical for Nuclear Medicine as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by Radiopharmaceutical for Nuclear Medicine Revenue in 2023
 Figure 21. North America Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America Radiopharmaceutical for Nuclear Medicine Market Share by Country (2019-2030)
 Figure 23. United States Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Radiopharmaceutical for Nuclear Medicine Market Share by Country (2019-2030)
 Figure 27. Germany Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Share by Region (2019-2030)
 Figure 35. China Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Japan Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. South Korea Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Southeast Asia Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. India Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Australia Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Radiopharmaceutical for Nuclear Medicine Market Share by Country (2019-2030)
 Figure 43. Mexico Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Brazil Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Share by Country (2019-2030)
 Figure 47. Turkey Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. UAE Radiopharmaceutical for Nuclear Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. NRG Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 51. NTP Radioisotopes Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 52. JSC Isotope Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 53. ANSTO Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 55. IRE ELIT Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 56. Nordion Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 57. Polatom Revenue Growth Rate in Radiopharmaceutical for Nuclear Medicine Business (2019-2024)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030
Oncology Radiopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Solutions Market Research Report 2024
Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024
Nuclear Medicine Imaging Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Radiopharmaceutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radioactive Medical Isotopes Market Research Report 2024
Targeted Radionuclide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Solutions Market Research Report 2025
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030
Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Management Software Market Research Report 2025
Global Nuclear Medicine System Market Insights Forecast to 2030
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radioactive Isotopes Market Research Report 2025
Nuclear Medicine Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Radioactive Isotopes Market Research Report 2025
Radiopharmaceutical Synthesizers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions